← Back to Clinical Trials
Recruiting NCT07097792

NCT07097792 Concussion Recovery and Support Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07097792
Status Recruiting
Phase —
Sponsor Seattle Children's Hospital
Condition Brain Concussion
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-10-13
Primary Completion 2026-07-21

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 29 Years
Study Type INTERVENTIONAL
Interventions
CRISP (Concussion Recovery and Support Program)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-10-13 with a primary completion date of 2026-07-21.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pilot randomized controlled trial (RCT) comparing a novel intervention Concussion Recovery and Support Program (CRISP) for adolescents and young adults (AYA) 18-29 yo with concussion/ mild TBI.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with a concussion and at least 2 weeks from injury but less than two years. * New or worsening headache since concussion * Had at least one day with headache last week of moderate severity or two days with headache of any severity Exclusion Criteria: * Non-English speaking * Chronic medical illness/ medical complexity * Housing instability * Acute mental health issues such as active suicidality, psychiatric hospitalization within the past 6 months, ER visit for suicidality in the past 6 months or experiencing psychosis or delusions

Contact & Investigator

Central Contact

Sara PD Chrisman, MD MPH

✉ crisp@seattlechildrens.org

📞 206-884-1490

Frequently Asked Questions

Who can join the NCT07097792 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 29 Years, studying Brain Concussion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07097792 currently recruiting?

Yes, NCT07097792 is actively recruiting participants. Contact the research team at crisp@seattlechildrens.org for enrollment information.

Where is the NCT07097792 trial being conducted?

This trial is being conducted at Seattle, United States, Seattle, United States.

Who is sponsoring the NCT07097792 clinical trial?

NCT07097792 is sponsored by Seattle Children's Hospital. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology